Ribonuclease/angiogenin Inhibitor 1 (RNH1) (Middle Region) Peptide
Quick Overview for Ribonuclease/angiogenin Inhibitor 1 (RNH1) (Middle Region) Peptide (ABIN983107)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RNH1 antibody (Catalog #: ARP57822_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- RNH1 (Ribonuclease/angiogenin Inhibitor 1 (RNH1))
-
Background
-
RNH1 is the inhibitor of pancreatic RNase and angiogenin. RNH1 may also function in the modulation of cellular activities.
Alias Symbols: MGC18200, MGC4569, MGC54054, RAI, RNH
Protein Interaction Partner: ANG,RNASE1,ANG,C20orf94,G3BP2,LOC220594,TNFAIP3
Protein Size: 461 -
Molecular Weight
- 50 kDa
-
Gene ID
- 6050
-
NCBI Accession
- NM_203387, NP_976321
-
UniProt
- P13489
Target
-